lorazepam has been researched along with 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n-propylcinnoline-3-carboxamide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Cohen, A; Cross, AJ; de Kam, M; Jacobs, G; Jaeger, J; Lappalainen, J; Maruff, P; Smith, MA; van Gerven, J | 1 |
Chen, X; Cross, AJ; de Kam, ML; Hay, JL; Jacobs, GE; Lappalainen, J; Nahon, KJ; Te Beek, ET; van Gerven, JM | 1 |
2 trial(s) available for lorazepam and 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n-propylcinnoline-3-carboxamide
Article | Year |
---|---|
The central nervous system effects of the partial GABA-Aα2,3 -selective receptor modulator AZD7325 in comparison with lorazepam in healthy males.
Topics: Adult; Brain; Cross-Over Studies; Double-Blind Method; Electroencephalography; GABA Modulators; Heterocyclic Compounds, 2-Ring; Humans; Lorazepam; Male; Receptors, GABA-A | 2014 |
The effects of the nonselective benzodiazepine lorazepam and the α2 /α3 subunit-selective GABAA receptor modulators AZD7325 and AZD6280 on plasma prolactin levels.
Topics: Adolescent; Adult; Biomarkers; Cross-Over Studies; Double-Blind Method; GABA Modulators; Germany; Healthy Volunteers; Heterocyclic Compounds, 2-Ring; Humans; Lorazepam; Male; Middle Aged; Prolactin; Receptors, GABA-A; Young Adult | 2015 |